5995 studies found for:    breast,cancer,treatment
Show Display Options
Rank Status Study
1 Completed Understanding Shared Psychobiological Pathways
Condition: Breast Neoplasms
Interventions: Behavioral: Education;   Behavioral: Peer support
2 Active, not recruiting Hula, a Physical Activity Intervention for Breast Cancer Survivors
Conditions: Physical Activity;   Breast Cancer
Intervention: Behavioral: Hula
3 Recruiting A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Condition: Vaginal Atrophy
Interventions: Drug: estriol;   Drug: Placebo
4 Unknown  Stress Management in Breast Cancer Patients
Conditions: Breast Cancer;   Stress
Intervention: Behavioral: Stress management, in two steps
5 Active, not recruiting Cognitive Changes Associated With Breast Cancer Treatment
Conditions: Breast Cancer;   Cognitive Side Effects of Cancer Treatments;   Stage I, II and III A Breast Cancer
Intervention: Behavioral: Questionnaires, MRI, Comet assay and Cell senescence
6 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate
7 Completed Predictive Model of Therapy Outcomes in Breast Cancer Patients
Condition: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
8 Active, not recruiting Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation
Condition: Cancer of the Breast
Interventions: Procedure: Surgery for breast cancer;   Other: No Loco-regional treatment
9 Completed
Has Results
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Conditions: Breast Cancer;   Dermatologic Complications;   Radiation Toxicity;   Skin Reactions Secondary to Radiation Therapy
Interventions: Drug: mometasone furoate;   Other: placebo
10 Active, not recruiting Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Multi-Beam Intensity-Modulated Radiation Therapy
11 Completed Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors
Conditions: Breast Cancer;   Cancer Survivor;   Fatigue;   Long-term Effects Secondary to Cancer Therapy in Adults;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Behavioral: exercise intervention;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: survey administration;   Procedure: assessment of therapy complications;   Procedure: fatigue assessment and management;   Procedure: management of therapy complications;   Procedure: psychosocial assessment and care
12 Completed Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
Conditions: Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   Tubular Breast Cancer Stage III;   HER-2 Positive Breast Cancer;   Inflammatory Breast Cancer Stage IV;   Inflammatory Breast Cancer
Interventions: Drug: Carboplatin;   Drug: background treatment according to standards fpr triple negative and Her2pos breast cancer patients
13 Completed Breast Cancer With Over-expression of erbB2-BRAINSTORM
Condition: Cancer
Intervention: Drug: Anti-erbB2 therapy as part of a treatment regimen for either brain metastases or primary breast cancer
14 Recruiting Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Conditions: Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Positive;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Aromatase Inhibition Therapy;   Drug: Carboplatin;   Other: Cytology Specimen Collection Procedure;   Drug: Docetaxel;   Drug: Goserelin Acetate;   Other: Laboratory Biomarker Analysis;   Biological: Pertuzumab;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery;   Biological: Trastuzumab;   Radiation: Whole Breast Irradiation
15 Terminated Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Other: Genomic and Proteomic Profiling
16 Active, not recruiting Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Condition: Breast Cancer
Interventions: Radiation: Whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy;   Radiation: Higher per daily radiation therapy;   Radiation: Concurrent boost radiotherapy;   Radiation: Standard per daily radiation therapy;   Radiation: Sequential boost radiotherapy
17 Completed Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Procedure: adjuvant therapy
18 Active, not recruiting Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Conditions: Estrogen Receptor Negative;   Estrogen Receptor Positive;   HER2/Neu Negative;   Male Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Biological: Bevacizumab;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Placebo;   Other: Quality-of-Life Assessment
19 Terminated Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: methotrexate;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: adjuvant therapy;   Radiation: radiation therapy
20 Terminated Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
Conditions: Breast Cancer;   Cognitive/Functional Effects;   Colorectal Cancer;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Behavioral: compliance monitoring;   Drug: systemic chemotherapy;   Other: medical chart review;   Other: study of socioeconomic and demographic variables;   Other: survey administration;   Procedure: cognitive assessment;   Procedure: psychosocial assessment and care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years